A Real-World Experience With Resmetirom: Tolerability and Access
Resmetirom is a safe medication with good tolerability in regard to the side effect profile for the first 3 months. Most patients were able to gain insurance approval but delays in dispensing and insurance requirements of invasive fibrosis testing to obtain approval were observed.
Authors
- James Gore
- George Therapondos (ORCID: https://orcid.org/0000-0002-6113-4972)
- Sameera Shuaibi
- Ruona Ebiai
- Ian Tobal
- Claire Ozoral
Institutions
- Ochsner Health System (US)
Publication Details
- Journal
- Gastro Hep Advances
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.gastha.2025.100709
- Citations
- 7
- Primary Topic
- Pain Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.15